Actively Recruiting
Pilot Study of Two Intermittent Theta-Burst Stimulation Schedules for Depression with Post-COVID-19 Condition Assessing Immune and Clinical Effects
Led by Max-Planck-Institute of Psychiatry · Updated on 2026-10-07
42
Participants Needed
1
Research Sites
34 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the effects of two different schedules of intermittent theta-burst stimulation iTBS on patients with depression and Post-COVID-19 condition PCC. This randomized pilot study is conducted at the Max Planck Institute of Psychiatry, Munich, and aims to evaluate changes in immune blood markers and depressive symptoms. The study explores how standard and intensified iTBS treatments may influence neuroinflammatory processes and clinical outcomes in this population. Participants are randomly assigned to one of two groups. The Standard Arm receives one iTBS session per day, five days a week, over six weeks, totaling 30 sessions. The Intensified Arm receives six sessions per day for five consecutive days, also totaling 30 sessions. Each session involves stimulation of the left dorsolateral prefrontal cortex at 90% resting motor threshold using a PowerMAG 100 ppTMS device, with sessions lasting about 3 minutes each. Throughout the study, participants undergo assessments of inflammatory blood markers including CRP, TNF, IL-1, and IL-6 at baseline, mid-treatment, and after treatment completion. Depressive symptoms are measured with the Beck Depression Inventory-II and the Montgomery-Asberg Depression Rating Scale. Additional evaluations include fatigue, sleep quality, daytime sleepiness, functioning, anxiety, and adverse effects. Follow-up assessments occur three days and three months post-treatment. Blood samples are collected and securely stored for analysis, while safety and tolerability are continuously monitored.
CONDITIONS
Brief Title
IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition
Research Team
A
Alexandros Balaskas, MD
A
Angelika Erhardt-Lehmann, MD, Prof.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here